Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2830-2835

  De Cosmo, Salvatore ^a   Copetti, Massimiliano ^a   Lamacchia, Olga ^b   Fontana, Andrea ^a   Massa, Michela ^a   Morini, Eleonora ^a   Pacilli, Antonio ^a   Fariello, Stefania ^b   Palena, Antonio ^a   Rauseo, Anna ^a   Viti, Rafaella ^a   Di Paola, Rosa ^a   Menzaghi, Claudia ^a   Cignarelli, Mauro ^b   Pellegrini, Fabio ^a,c   Trischitta, Vincenzo ^a,d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAUSE OF DEATH; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOGGIA MORTALITY STUDY; FOLLOW UP; GARGANO MORTALITY STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONBIOLOGICAL MODEL; OUTCOME ASSESSMENT; PREDICTION; PROCESS DEVELOPMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; URINALYSIS; VALIDATION PROCESS;

AGED; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROSPECTIVE STUDIES;

EID: 84890547353     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1906     Document Type: Article

References (31)

1. The Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific deaths. N Engl J Med 2011;364: 829-841
2. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005;28: 2130-2135
3. International Diabetes Federation (IDF). Diabetes atlas (e-Atlas) [Internet]. Available from http://www.eatlas.idf.org/ index2983.html. Accessed 2 September 2012
4. Yang X, So WY, Tong PC, et al.; Hong Kong Diabetes Registry. Development and validation of an all-cause mortality risk score in type 2 diabetes. Arch Intern Med 2008;168: 451-457
5. Wells BJ, Jain A, Arrigain S, Yu C, Rosenkrans WA, Jr, Kattan MW. Predicting 6-year mortality risk in patients with type 2 diabetes. Diabetes Care 2008;31: 2301-2306
6. McEwen LN, Karter AJ, Waitzfelder BE, et al. Predictors ofmortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012;35: 1301-1309
7. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004;23: 2109-2123
8. D'Agostino RB, Nam BH. Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures. Handbook of Statistics. Vol 23. Amsterdam, the Netherlands, Elsevier Science B.V., 2004
9. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21: 128-138
10. Steyerberg EW, Pencina MJ. Reclassification calculations for persons with incomplete follow-up. Ann Intern Med 2010;152: 195-196
11. Pencina MJ, D'Agostino RB, Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30: 11-21
12. Pencina MJ, D'Agostino RB, Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nestedmodels. Stat Med 2012;31: 101-113
13. Levey AS, Greene T, Kusek JW, et al. A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract). J Am Soc Nephrol 2000;11:155A
14. Pencina MJ, D'Agostino RB, Sr, D'Agostino RB, Jr, Vasan RS. Evaluating the added predictive ability of a new marker: fromarea under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-212
15. Lin DY, Wei LJ. The robust inference for the Cox proportional hazardsmodel. J Am Stat Ass 1989;84: 1074-1078
16. Ciampi A. Generalized regression trees. Comput Stat Data Anal 1991;12: 57-78
17. Addante F, Sancarlo D, Copetti M, et al. Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients. Rejuvenation Res 2011;14: 111-118
18. Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J AmColl Cardiol 2010;55: 2556-2566
19. Collins GS, Altman DG. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 2012;344:e4181
20. Stevens RJ, Kothari V, Adler AI, Stratton IM; United KingdomProspective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101: 671-679
21. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. NatGenet 2006;38: 209-213
22. Weedon MN, McCarthy MI, Hitman G, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 2006;3:e374
23. Barzi F, Woodward M. Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiol 2004;160: 34-45
24. Miettinen H, Lehto S, Salomaa VV, et al.; The FINMONICA Myocardial Infarction Register Study Group. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 1998;21: 69-75
25. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with olderonset diabetes mellitus. Arch Intern Med 2000;160: 1093-1100
26. Solomon SD, Lin J, Solomon CG, et al.; Prevention of Events With ACE Inhibition (PEACE) Investigators. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 2007;116: 2687-2693
27. Khaw KT, Barrett-Connor E, Suarez L, Criqui MH. Predictors of stroke-associated mortality in the elderly. Stroke 1984;15: 244-248
28. Smooke S, Horwich TB, Fonarow GC. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J 2005;149: 168-174
29. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143-3421
30. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012;308: 581-590
31. Anderson RJ, Bahn GD, Moritz TE, Kaufman D, Abraira C, Duckworth W; VADT Study Group. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care 2011; 34: 34-38